| Absorption |
| Blood-Brain Barrier | BBB+ | 0.9692 |
| Human Intestinal Absorption | HIA+ | 1.0000 |
| Caco-2 Permeability | Caco2+ | 0.8223 |
| P-glycoprotein Substrate | Substrate | 0.7126 |
| P-glycoprotein Inhibitor | Inhibitor | 0.7243 |
| Non-inhibitor | 0.8906 |
| Renal Organic Cation Transporter | Non-inhibitor | 0.7693 |
| Distribution |
| Subcellular localization | Mitochondria | 0.8710 |
| Metabolism |
| CYP450 2C9 Substrate | Non-substrate | 0.8337 |
| CYP450 2D6 Substrate | Non-substrate | 0.9327 |
| CYP450 3A4 Substrate | Substrate | 0.7512 |
| CYP450 1A2 Inhibitor | Non-inhibitor | 0.9533 |
| CYP450 2C9 Inhibitor | Non-inhibitor | 0.9434 |
| CYP450 2D6 Inhibitor | Non-inhibitor | 0.9412 |
| CYP450 2C19 Inhibitor | Non-inhibitor | 0.7874 |
| CYP450 3A4 Inhibitor | Non-inhibitor | 0.8711 |
| CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.9270 |
| Excretion |
| Toxicity |
| Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.9562 |
| Non-inhibitor | 0.7248 |
| AMES Toxicity | Non AMES toxic | 0.9182 |
| Carcinogens | Non-carcinogens | 0.9568 |
| Fish Toxicity | High FHMT | 0.9924 |
| Tetrahymena Pyriformis Toxicity | High TPT | 0.9452 |
| Honey Bee Toxicity | High HBT | 0.8027 |
| Biodegradation | Not ready biodegradable | 0.9596 |
| Acute Oral Toxicity | IV | 0.6859 |
| Carcinogenicity (Three-class) | Non-required | 0.4722 |